文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ARDS中的肺修复与再生:PECAM1与Wnt信号通路的作用

Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling.
PubMed 文献 · Chest · 2018-10-28
一句话结论综述指出PECAM1参与维持和恢复血管完整性,Wnt信号通路似乎是肺愈合及纤维化发展的核心机制,ARDS目前无特异性药物治疗,住院死亡率约40%。

ARDS是由严重肺部和全身性打击触发肺泡-毛细血管膜的急性炎症性肺部过程,导致血管通透性增加、间质和肺泡富含蛋白的水肿,引起急性低氧性呼吸衰竭。支持治疗包括肺保护性通气策略,可减少呼吸做功、改善氧合、尽量减少呼吸机相关肺损伤。尽管支持措施有显著进展,ARDS仍无特异性药物治疗,多数系列中总住院死亡率约40%。本文综述肺损伤分子基础的新进展,聚焦于血小板-内皮细胞黏附分子-1(PECAM1)和Wnt信号通路作为潜在药物干预靶点。

要点

  • ARDS由严重肺部和全身性打击触发肺泡-毛细血管膜急性炎症,导致血管通透性增加和富含蛋白的水肿,引起急性低氧性呼吸衰竭。
  • 支持治疗包括肺保护性通气策略,可减少呼吸做功、改善氧合、尽量减少呼吸机相关肺损伤。
  • 尽管支持措施有显著进展,ARDS仍无特异性药物治疗,多数系列中总住院死亡率约40%。
  • PECAM1参与屏障破坏后血管完整性的维持和恢复,是综述重点讨论的潜在药物干预靶点。
  • Wnt信号通路似乎是肺愈合以及纤维化发展的核心机制,亦为综述重点讨论的潜在干预方向。

适用人群与场景

  • ARDS患者,即由严重肺部和全身性打击触发肺泡-毛细血管膜急性炎症、导致急性低氧性呼吸衰竭的人群。

处置流程与药物剂量

  • 支持治疗包括使用肺保护性通气策略,可减少呼吸做功、改善氧合、尽量减少呼吸机相关肺损伤。

研究设计与关键结果

  • 综述聚焦肺损伤分子基础的新进展,重点讨论PECAM1(参与屏障破坏后血管完整性的维持和恢复)和Wnt信号通路(似乎是肺愈合及纤维化发展的核心机制)作为潜在药物干预靶点。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

ARDS is an acute inflammatory pulmonary process triggered by severe pulmonary and systemic insults to the alveolar-capillary membrane. This causes increased vascular permeability and the development of interstitial and alveolar protein-rich edema, leading to acute hypoxemic respiratory failure. Supportive treatment includes the use of lung-protective ventilatory strategies that decrease the work of breathing, can improve oxygenation, and minimize ventilator-induced lung injury. Despite substantial advances in supportive measures, there are no specific pharmacologic treatments for ARDS, and the overall hospital mortality rate remains about 40% in most series. The pathophysiology of ARDS involves interactions among multiple mechanisms, including immune cell infiltration, cytokine storm, alveolar-capillary barrier disruption, cell apoptosis, and the development of fibrosis. Here we review some new developments in the molecular basis of lung injury, with a focus on possible novel pharmacologic interventions aimed at improving the outcomes of patients with ARDS. Our focus is on platelet-endothelial cell adhesion molecule-1, which contributes to the maintenance and restoration of vascular integrity following barrier disruption. We also highlight the wingless-related integration site signaling pathway, which appears to be a central mechanism for lung healing as well as for fibrotic development.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Villar J, Zhang H, Slutsky AS, et al. Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling. Chest. 2018. PMID: 30392791. doi:10.1016/j.chest.2018.10.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。